Julien Milhau

The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.

J. Bilello, S. Cappelle, I. Serra, 2017, Bioorganic & medicinal chemistry letters.

Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor.

Catherine Caillet, J. McCarville, M. Liuzzi, 2017, Bioorganic & medicinal chemistry letters.

N-1H-benzimidazol-5-ylbenzenesulfonamide derivatives as potent hPXR agonists.

J. Pascussi, A. Mallavialle, W. Bourguet, 2008, Bioorganic & medicinal chemistry.

Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.

J. McCarville, M. Liuzzi, Cyril Dousson, 2016, Bioorganic & medicinal chemistry letters.

N-1H-benzimidazol-5-ylbenzenesulfonamide derivatives as potent hPXR agonists.

J. Pascussi, W. Bourguet, J. Guichou, 2008, Bioorganic & medicinal chemistry.